
CAS 95716-98-6
:Formel:C24H31KO7
InChl:InChI=1S/C24H32O7.K/c1-21-7-4-14(25)10-13(21)11-15(20(28)30-3)19-16-5-8-23(29,9-6-18(26)27)22(16,2)12-17-24(19,21)31-17;/h10,15-17,19,29H,4-9,11-12H2,1-3H3,(H,26,27);/q;+1/p-1/t15-,16+,17-,19+,21+,22+,23-,24-;/m1./s1
InChI Key:PRKXKJMKEHYPBV-PUDZRVQSSA-M
SMILES:C[C@]12CCC(=O)C=C1C[C@H]([C@@H]3[C@]24[C@H](O4)C[C@]5([C@H]3CC[C@]5(CCC(=O)[O-])O)C)C(=O)OC.[K+]
Filtern nach
Reinheitsanteil
0
100
|
0
|
50
|
90
|
95
|
100
5 Produkte gefunden.
- Niedrigster Preis
- Höchster Preis
- Niedrigste Reinheit
- Höchste Reinheit
- Schnellste Lieferung
Eplerenone EP Impurity F Potassium salt
CAS:Formel:C24H31O7·KFarbe und Form:White To Off-White SolidMolekulargewicht:431.51 39.109,11α-Epoxy-17-hydroxy-7α-(methoxycarbonyl)-3-oxo-17α-pregn-4-ene-21-carboxylic Acid Potassium Salt
CAS:Formel:C24H31O7·KFarbe und Form:NeatMolekulargewicht:470.6Eplerenone Hydroxyacid Potassium Salt
CAS:Kontrolliertes ProduktApplications A metabolite of Eplerenone. Used in combination therapy for treatment of cardiovascular disorders.
References Staessen, J., et al.: J. Endocrinol., 91, 457 (1981), de Gasparo, M., et al.: J. Pharmacol. Exp. Ther., 240, 650 (1987), MacFadyen, R., et al.: Cardiovasc. Res., 35, 30 (1997),Formel:C24H31O7·KFarbe und Form:NeatMolekulargewicht:470.6Eplerenone-methyl-d3 Hydroxyacid Potassium Salt
CAS:Kontrolliertes ProduktApplications A labelled metabolite of Eplerenone. Used in combination therapy for treatment of cardiovascular disorders.
References Staessen, J., et al.: J. Endocrinol., 91, 457 (1981), de Gasparo, M., et al.: J. Pharmacol. Exp. Ther., 240, 650 (1987), MacFadyen, R., et al.: Cardiovasc. Res., 35, 30 (1997),Formel:C24D3H28KO7Farbe und Form:NeatMolekulargewicht:473.615Eplerenone hydroxyacid potassium salt
CAS:Eplerenone is a drug that belongs to the class of drugs known as selective mineralocorticoid receptor antagonists. It is a prodrug that is metabolized in vivo to its active form, eplerenone acid. Eplerenone inhibits the binding of aldosterone to its receptors in the kidney. Eplerenone hydroxyacid potassium salt has been shown to have stereochemical purity of >98% and no detectable process-related impurities or experimental impurities. High-performance liquid chromatography (HPLC) methods have been used to characterize this drug substance and confirm that it has an average particle size 10 micrometers with no particles > 150 micrometers.Formel:C24H31KO7Reinheit:Min. 95%Molekulargewicht:470.6 g/mol



